BioSpace News Archive

Correction of the press release published November 24, 2020: It has come to our attention that a mistake was printed in the percentage of control patients in the EAP who survived to day 28.

Supply chain analytics solution provider Logmore has announced the launch of its latest product. Logmore Dry Ice, a high-spec version of Logmore’s original data recorder, has been adapted for cold and sub-zero conditions

Medical purity analyzers refer to those instruments that are able to measure and determine quantitative and qualitative composition of mixtures of medical gases or pure medical gases.

The global plasma protease C1-inhibitor treatment market is foreseen to experience upward graph of revenues in the assessment period of 2019 to 2029.

908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. 908 Devices int

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) 40mg/10ml. DANYELZA is indicated, in combination with granulocyte-macrophage colony-stimulating factor (“GM-CS

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock™ and the upcoming lau

The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to advancing research and improving care for individuals living with sarcoidosis, announces the appointment of Elliott Crouser , MD as Chair of the organization’s Scientific Advisory Board (SAB). “Dr. Crouser is exceptionally well-respect

T.H.A.C Announces Leadership Transition Appointing Lyse Santoro Chief Executive Officer and Member of the Board of Directors Company founder Professor Christian Brechot, remains Executive Chairman of the Board and Chief Executive Officer of T.H.A.C USA affiliate

IsoPlexis, the leader in single-cell functional proteomics, announced today that Chief Executive Officer and Co-Founder, Sean Mackay , will present at Evercore ISI’s 3 rd Annual HealthCONx Conference on Wednesday, December 2 nd at 9:40 a.m. ET .